Cargando…

Oxidative stress biomarkers in Fabry disease: is there a room for them?

BACKGROUND: Fabry disease (FD) is an X-linked lysosomal storage disorder, caused by deficient activity of the alpha-galactosidase A enzyme leading to progressive and multisystemic accumulation of globotriaosylceramide. Recent data point toward oxidative stress signalling which could play an importan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simoncini, C., Torri, S., Montano, V., Chico, L., Gruosso, F., Tuttolomondo, A., Pinto, A., Simonetta, I., Cianci, V., Salviati, A., Vicenzi, V., Marchi, G., Girelli, D., Concolino, D., Sestito, S., Zedde, M., Siciliano, G., Mancuso, Michelangelo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674365/ https://www.ncbi.nlm.nih.gov/pubmed/32719972 http://dx.doi.org/10.1007/s00415-020-10044-w

Ejemplares similares

Therapeutical Management and Drug Safety in Mitochondrial Diseases—Update 2020
por: Gruosso, Francesco, et al.
Publicado: (2020)

Gastrointestinal Symptoms of Patients with Fabry Disease
por: Pensabene, Licia, et al.
Publicado: (2016)

Biomarkers in Anderson–Fabry Disease
por: Simonetta, Irene, et al.
Publicado: (2020)

Pathophysiology and Management of Fatigue in Neuromuscular Diseases
por: Torri, Francesca, et al.
Publicado: (2023)

CPEO and Mitochondrial Myopathy in a Patient with DGUOK Compound Heterozygous Pathogenetic Variant and mtDNA Multiple Deletions
por: Montano, V., et al.
Publicado: (2019)

Proximal Myopathy due to m.5835G>A Mutation in Mitochondrial MT-TY Gene
por: Simoncini, C., et al.
Publicado: (2018)

Mitochondrial ANT-1 related adPEO leading to cognitive impairment: is there a link?
por: Simoncini, Costanza, et al.
Publicado: (2017)

Co-existence of Phenylketonuria and Fabry disease on a 3 year-old boy: case report
por: Concolino, Daniela, et al.
Publicado: (2010)

Urine Bikunin as a Marker of Renal Impairment in Fabry's Disease
por: Lepedda, Antonio Junior, et al.
Publicado: (2013)

Genetic variants associated with gastrointestinal symptoms in Fabry disease
por: Di Martino, Maria Teresa, et al.
Publicado: (2016)

Genetic variants associated with Fabry disease progression despite enzyme replacement therapy
por: Scionti, Francesca, et al.
Publicado: (2017)

Effects of aerobic training on exercise-related oxidative stress in mitochondrial myopathies
por: Siciliano, Gabriele, et al.
Publicado: (2012)

NEWS and VIEWS: mitochondrial encephalomyopathies
por: Ienco, Elena Caldarazzo, et al.
Publicado: (2016)

Pathogenesis and Molecular Mechanisms of Anderson–Fabry Disease and Possible New Molecular Addressed Therapeutic Strategies
por: Tuttolomondo, Antonino, et al.
Publicado: (2021)

Mitochondrial Ataxias: Molecular Classification and Clinical Heterogeneity
por: Lopriore, Piervito, et al.
Publicado: (2022)

Mitochondrial Epilepsy, a Challenge for Neurologists
por: Lopriore, Piervito, et al.
Publicado: (2022)

May “Mitochondrial Eve” and Mitochondrial Haplogroups Play a Role in Neurodegeneration and Alzheimer's Disease?
por: Ienco, Elena Caldarazzo, et al.
Publicado: (2011)

FAbry STabilization indEX (FASTEX): an innovative tool for the assessment of clinical stabilization in Fabry disease
por: Mignani, Renzo, et al.
Publicado: (2016)

Primary mitochondrial myopathy: 12-month follow-up results of an Italian cohort
por: Montano, V., et al.
Publicado: (2022)

Case report: De novo mutation of a-galactosidase A in a female patient with end-stage renal disease: report of a case of late diagnosis of Anderson–Fabry disease
por: Simonetta, Irene, et al.
Publicado: (2023)

Exercise-Related Oxidative Stress as Mechanism to Fight Physical Dysfunction in Neuromuscular Disorders
por: Siciliano, Gabriele, et al.
Publicado: (2020)

Anderson–Fabry Disease: A New Piece of the Lysosomal Puzzle in Parkinson Disease?
por: Zedde, Marialuisa, et al.
Publicado: (2022)

Oxidative Stress in Cerebral Small Vessel Disease Dizziness Patients, Basally and After Polyphenol Compound Supplementation
por: Ulivi, L., et al.
Publicado: (2018)

Electrocardiogram analysis in Anderson-Fabry disease: a valuable tool for progressive phenotypic expression tracking
por: Parisi, V., et al.
Publicado: (2023)

The losses measurement for optical cavity with Fabry-Perot etalon
por: Pinayev, I V, et al.
Publicado: (1993)

Revealing the Complexity of Mitochondrial DNA-Related Disorders
por: Orsucci, Daniele, et al.
Publicado: (2018)

Mitochondrial m.3243A > G mutation and carotid artery dissection
por: Mancuso, Michelangelo, et al.
Publicado: (2016)

Inter-familial and intra-familial phenotypic variability in three Sicilian families with Anderson-Fabry disease
por: Tuttolomondo, Antonino, et al.
Publicado: (2017)

An overview of automated room disinfection systems: When to use them and how to choose them
por: Otter, J.A., et al.
Publicado: (2020)

Nervous system and Fabry disease, from symptoms to diagnosis: damage evaluation and follow-up in adult patients, enzyme replacement, and support therapy
por: Salviati, Alessandro, et al.
Publicado: (2010)

Alzheimer's Pathogenesis and Its Link to the Mitochondrion
por: Simoncini, C., et al.
Publicado: (2015)

Antibodies against recombinant enzyme in the treatment of Fabry disease: Now you see them, now you don’t
por: van der Veen, Sanne Jolien, et al.
Publicado: (2022)

Primary mitochondrial myopathy: Clinical features and outcome measures in 118 cases from Italy
por: Montano, Vincenzo, et al.
Publicado: (2020)

Current and emerging treatment options in the management of Friedreich ataxia
por: Mancuso, Michelangelo, et al.
Publicado: (2010)

Tetracyclines and Neuromuscular Disorders
por: Orsucci, Daniele, et al.
Publicado: (2012)

Mitochondrial DNA sequence variation and neurodegeneration
por: Mancuso, Michelangelo, et al.
Publicado: (2008)

Fabry-Stroke Italian Registry (FSIR): a nationwide, prospective, observational study about incidence and characteristics of Fabry-related stroke in young-adults. Presentation of the study protocol
por: Romani, Ilaria, et al.
Publicado: (2021)

Nucleon polarizabilities and the methods for measuring them
por: Petrunkin, V A, et al.
Publicado: (1988)

Newborn Screening for Fabry Disease in Northeastern Italy: Results of Five Years of Experience
por: Gragnaniello, Vincenza, et al.
Publicado: (2021)

Lack of Association between Nuclear Factor Erythroid-Derived 2-Like 2 Promoter Gene Polymorphisms and Oxidative Stress Biomarkers in Amyotrophic Lateral Sclerosis Patients
por: LoGerfo, Annalisa, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_pg29iqg0kb3nhm134vksr6ih2a